Advertisement

Awareness of sensory decline in patients with type 2 diabetes mellitus

  • Aline B. Herrera-Rangel
  • Catalina Aranda-Moreno
  • María Teresa Mantilla-Ochoa
  • Ana Lilia Zainos-Saucedo
  • Kathrine Jáuregui-RenaudEmail author
Short Article

Abstract

The goal of this paper is to assess the awareness of sensory impairment and balance decline in middle-aged patients with type 2 diabetes mellitus, receiving primary health care. Ninety-nine patients aged ≤65 years participated in the study. They were evaluated by clinical interview, a questionnaire of balance and specialized audiology, ophthalmology, peripheral neuropathy, and vestibular assessments. Although 52 patients (52 %, 95 % C.I. 42–62 %) had impairment of at least two senses, they were not aware of their sensory dysfunction or balance decline. Intentional questioning was not enough to detect hearing or visual deterioration but suggested somatosensory or vestibular dysfunction. Even the occurrence of frequent falls was underreported, unless intentionally investigated. The results support that education strategies are needed to increase awareness of sensory and balance decline in both patients and primary care professionals.

Keywords

Diabetes mellitus Sensory decline Hearing loss Vision Polyneuropathy Balance 

Notes

Acknowledgments

We thank Niels Watcher Rodarte, Rita Gómez Díaz, and Anabel Meza Urquiza for their contribution to identify candidates to participate in the study. Funding by CONACyT (SALUD-2010-02-151394) and by Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/1034).

Conflict of interest

None declared.

References

  1. 1.
    Deepa M, Bhansali A, Anjana RM, Pradeepa R, Joshi SR, Joshi PP, et al. Knowledge and awareness of diabetes in urban and rural India: the Indian Council of Medical Research India Diabetes Study (Phase I): Indian Council of Medical Research India Diabetes 4. Indian J Endocrinol Metab. 2014;18:379–85.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Baba M, Foley L, Davis WA, Davis TM. Self-awareness of foot health status in patients with Type 2 diabetes: the Fremantle Diabetes Study Phase II. Diabet Med. 2014;31(11):1439–45.PubMedCrossRefGoogle Scholar
  3. 3.
    Jáuregui-Renaud K, Gutiérrez MA, Viveros RL, Villanueva PL. Síntomas de Inestabilidad Corporal y Enfermedad Vestibular. Rev Med Instit Mex Seguro Soc 2003; 41:373–8. Open access: http://www.medigraphic.com/pdfs/imss/im-2003/im035b.pdf
  4. 4.
    Jáuregui-Renaud K, Sánchez B, Ibarra Olmos A, González-Barcena D. Neurootologic symptoms in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009;84:45–7.CrossRefGoogle Scholar
  5. 5.
    de León-Morales LV D, Jáuregui-Renaud K, Garay-Sevilla ME, Hernández-Prado J, Malacara-Hernández J. Auditory impairment in patients with type 2 diabetes mellitus. Arch Med Res. 2005;36:507–10.CrossRefGoogle Scholar
  6. 6.
    Jáuregui-Renaud K, Gutierrez-Marquez A, Viveros-Rentería L, Ramos-Toledo V, Gómez-Alvarez F. Neurotology symptoms at referral to vestibular evaluation. J Otolaryngol Head Neck Surg 2013; 26;42:55. Open access: http://www.biomedcentral.com/content/pdf/1916-0216-42-55.pdf
  7. 7.
    Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–9.PubMedCrossRefGoogle Scholar
  8. 8.
    England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64:199–207.PubMedCrossRefGoogle Scholar
  9. 9.
    World Health Organization. Global estimates on prevalence of hearing loss. In: Mortality and Burden of Diseases and Prevention of Blindness and Deafness. WHO, 2012.Google Scholar
  10. 10.
    World Health Organization. Diabetes, Fact sheet N°312. Updated January 2015. http://www.who.int/mediacentre/factsheets/fs312/en/, visited March 9, 2015.
  11. 11.
    Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88:1254–64.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Cullen JR, Cinamond MJ. Hearing loss in diabetics. J Laryngol Otol. 1993;107:179–82.PubMedCrossRefGoogle Scholar
  13. 13.
    de Espana R, Biurrun O, Lorente J, Trasera J. Hearing and diabetes. ORL J Otorhinolaryngol Relat Spec. 1995;57:325–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Comi G. Evoked potentials in diabetes mellitus. Clin Neurosci. 1997;4:374–9.PubMedGoogle Scholar
  15. 15.
    Nicholson M, King J, Smith PF, Darlington CL. Vestibulo-ocular, optokinetic and postural function in diabetes mellitus. Neuroreport. 2002;21:153–7.CrossRefGoogle Scholar
  16. 16.
    Levine DN. Unawareness of visual and sensorimotor defects: a hypothesis. Brain Cogn. 1990;13:233–81.PubMedCrossRefGoogle Scholar
  17. 17.
    Schandry R, Lobisch M. Importance of sensory symptoms in identifying patients with diabetic peripheral neuropathy. Pract Diabetes Int. 2007;24:25–8.CrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2015

Authors and Affiliations

  • Aline B. Herrera-Rangel
    • 1
  • Catalina Aranda-Moreno
    • 2
  • María Teresa Mantilla-Ochoa
    • 2
  • Ana Lilia Zainos-Saucedo
    • 3
  • Kathrine Jáuregui-Renaud
    • 1
    Email author
  1. 1.Unidad de Investigación Médica en Otoneurología, Planta baja del Edificio C-Salud en el TrabajoCentro Médico Nacional siglo XXI, IMSSD.F.México
  2. 2.Hospital Regional 72 IMSSEstado de MéxicoMéxico
  3. 3.Hospital de Pediatría, CMN sXXI IMSSD.F.México

Personalised recommendations